UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 338

Sortiert nach

THU0074 Impact of The Discordance between C-Reactive Protein and Erythrocyte Sedimentation Rate on Clinical Response To Combination Etanercept-Methotrexate Therapy in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.205-206

2016

Volltextzugriff (PDF)

THU0235 The Role of C-Reactive Protein as a Predictor of Treatment Response in Patients with Ankylosing Spondylitis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.281-282

2015

Volltextzugriff (PDF)

Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response

Clinical and experimental rheumatology, 2017-01, Vol.35 (1), p.141

2017

Volltextzugriff (PDF)

SAT0407 Baseline Characteristics in Psoriasis Patients with Polyarthritis or Oligoarthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.742

2014

Volltextzugriff (PDF)

FRI0260 High Rates of Remission Induction Achieved with Combination Etanercept Plus Methotrexate in Early Rheumatoid Arthritis up to One Year after Symptom Onset

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.477

2014

Volltextzugriff (PDF)

THU0031 Baseline Characteristics and Treatment Outcomes of Patients Who Achieve Deep Remission in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.188

2016

Volltextzugriff (PDF)

Impact of early vs. late disease onset on treatment response to etanercept in patients with psoriasis

British journal of dermatology (1951), 2015-11, Vol.173 (5), p.1271-1273

2015

Volltextzugriff (PDF)

AB0261 Profile of an under-studied rheumatoid arthritis (RA) population: characteristics of patients with moderately active rheumatoid arthritis despite methotrexate use

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.652-652

2013

Volltextzugriff (PDF)

FRI0094 Relationship between disease duration and response to combination etanercept (ETN)-methotrexate (MTX) therapy in subjects with moderately active rheumatoid arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.341-341

2013

Volltextzugriff (PDF)

FRI0090 Radiographic progression in patients with early rheumatoid arthritis treated with etanercept: results from the prize study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A399-A400

2013

Volltextzugriff (PDF)

SAT0395 Scalp Psoriasis as A Surrogate Marker for Psoriatic Arthritis Severity and Treatment Response

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.737-737

2014

Volltextzugriff (PDF)

FRI0130 Continuation of Etanercept Monotherapy After Achievement of Remission with Etanercept and Methotrexate Combination Therapy: Subanalysis from the Comet Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.468-468

2015

Volltextzugriff (PDF)

THU0073 DAS28-CRP and DAS28-ESR Cutoffs for High Disease Activity in Rheumatoid Arthritis Are Not Interchangeable

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.205

2016

Volltextzugriff (PDF)

SAT0378 Modification of Structural Lesions on Magnetic Resonance Imaging by Etanercept: A 12-Week Randomized Placebo-Controlled Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.804-805

2016

Volltextzugriff (PDF)

SAT0296 Comparison of Clinical Cut-Offs For Diagnosis of Psoriatic Arthritis in Psoriasis Patients in European/North American Dermatology Clinics

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A683-A684

2013

Volltextzugriff (PDF)

SAT0071 Early Initiated Etanercept Plus Methotrexate Treatment Induces Remission in Patients with Either Moderate or Severe Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A603-A604

2013

Volltextzugriff (PDF)

SAT0584 Comparative Performance of Rapid3 (Routine Assessment of Patient Index Data 3) Versus Other Composite Indices in Clinical Trials of Psoriatic Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.872-872

2015

Volltextzugriff (PDF)

AB0861 Relationship between disease duration and treatment response in patients with ankylosing spondylitis (AS)

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.687-687

2013

Volltextzugriff (PDF)

FRI0164 Predictors of loss of clinical remission with etanercept 50 mg, 25 mg or placebo combined with methotrexate in moderate rheumatoid arthritis patients: Results of the preserve trial

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.367-367

2013

Volltextzugriff (PDF)

AB0287 Efficacy of etanercept (etn) plus methotrexate (mtx) vs. disease-modifying anti-rheumatic drug (dmard) combinations with mtx in established rheumatoid arthritis (ra): duration of disease and disease severity vs. outcomes

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A874-A874

2013

Volltextzugriff (PDF)

SAT0258 Baseline MRI/CRP as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.752

2015

Volltextzugriff (PDF)

AB0821 Baseline Characteristics of Patients with Moderate to Severe Psoriatic Arthritis: Post-Hoc Analysis of Responders vs Non-Responders to Etanercept

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1174-1174

2015

Volltextzugriff (PDF)

SAT0476 Impact of etanercept-methotrexate therapy on patient-reported outcomes in a randomized controlled trial in moderately active rheumatoid arthritis patients

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.633-633

2013

Volltextzugriff (PDF)

Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial

BMC dermatology, 2015-05, Vol.15 (1), p.9-9, Article 9

2015

Volltextzugriff (PDF)

PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia

Value in health, 2012-11, Vol.15 (7), p.A674-A674

2012

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(289)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

THU0074 Impact of The Discordance between C-Reactive Protein and Erythrocyte Sedimentation Rate on Clinical Response To Combination Etanercept-Methotrexate Therapy in Rheumatoid Arthritis

THU0235 The Role of C-Reactive Protein as a Predictor of Treatment Response in Patients with Ankylosing Spondylitis

Limited association between scalp psoriasis and psoriatic arthritis severity and treatment response

SAT0407 Baseline Characteristics in Psoriasis Patients with Polyarthritis or Oligoarthritis

FRI0260 High Rates of Remission Induction Achieved with Combination Etanercept Plus Methotrexate in Early Rheumatoid Arthritis up to One Year after Symptom Onset

THU0031 Baseline Characteristics and Treatment Outcomes of Patients Who Achieve Deep Remission in Rheumatoid Arthritis

Impact of early vs. late disease onset on treatment response to etanercept in patients with psoriasis

AB0261 Profile of an under-studied rheumatoid arthritis (RA) population: characteristics of patients with moderately active rheumatoid arthritis despite methotrexate use

FRI0094 Relationship between disease duration and response to combination etanercept (ETN)-methotrexate (MTX) therapy in subjects with moderately active rheumatoid arthritis

FRI0090 Radiographic progression in patients with early rheumatoid arthritis treated with etanercept: results from the prize study

SAT0395 Scalp Psoriasis as A Surrogate Marker for Psoriatic Arthritis Severity and Treatment Response

FRI0130 Continuation of Etanercept Monotherapy After Achievement of Remission with Etanercept and Methotrexate Combination Therapy: Subanalysis from the Comet Study

THU0073 DAS28-CRP and DAS28-ESR Cutoffs for High Disease Activity in Rheumatoid Arthritis Are Not Interchangeable

SAT0378 Modification of Structural Lesions on Magnetic Resonance Imaging by Etanercept: A 12-Week Randomized Placebo-Controlled Trial

SAT0296 Comparison of Clinical Cut-Offs For Diagnosis of Psoriatic Arthritis in Psoriasis Patients in European/North American Dermatology Clinics

SAT0071 Early Initiated Etanercept Plus Methotrexate Treatment Induces Remission in Patients with Either Moderate or Severe Rheumatoid Arthritis

SAT0584 Comparative Performance of Rapid3 (Routine Assessment of Patient Index Data 3) Versus Other Composite Indices in Clinical Trials of Psoriatic Arthritis

AB0861 Relationship between disease duration and treatment response in patients with ankylosing spondylitis (AS)

FRI0164 Predictors of loss of clinical remission with etanercept 50 mg, 25 mg or placebo combined with methotrexate in moderate rheumatoid arthritis patients: Results of the preserve trial

AB0287 Efficacy of etanercept (etn) plus methotrexate (mtx) vs. disease-modifying anti-rheumatic drug (dmard) combinations with mtx in established rheumatoid arthritis (ra): duration of disease and disease severity vs. outcomes

SAT0258 Baseline MRI/CRP as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis

AB0821 Baseline Characteristics of Patients with Moderate to Severe Psoriatic Arthritis: Post-Hoc Analysis of Responders vs Non-Responders to Etanercept

SAT0476 Impact of etanercept-methotrexate therapy on patient-reported outcomes in a randomized controlled trial in moderately active rheumatoid arthritis patients

Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial

PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia

Suchergebnisse filtern